In documents released today, the Pharmaceutical Benefits Advisory Committee (PBAC) explains it's decision to defer any recommendation to list simeprevir in combination with sofosbuvir on the Pharmaceutical Benefits Scheme (PBS).Read More
Hepatitis Australia posts news stories relating to viral hepatitis that may be relevant to people living with hepatitis B or C or the people working within the hepatitis health sector. News stories come from both international and Australian sources. Your comments are welcome but any inappropriate comments, or promotional comments will be removed.
The voice of the community can be powerful and Hepatitis Australia is calling on people living with, or affected by hepatitis C (HCV) to ‘Speak Out’ about their experiences. In particular, about how the current delay in access to the latest medicines is affecting them and what a cure will mean to them.Read More
Australia’s first national harm reduction organisation for individuals committed to reducing the health, social and economic harms potentially associated with drug use - Harm Reduction Australia (HRA) – was launched today at Parliament House in Canberra.Read More
A major report into the enormous value that Australians receive from government subsidised medicines has highlighted the dire need to address spiralling rates of liver disease by adding breakthrough hepatitis C medicines to the PBS.Read More